CD14 and COVID-19: Representative dot-plots illustrate the comparison of CD14+CD16+ non-classical monocytes expressing IFN-alpha in blood samples treated with polyclonal stimuli from participants who developed mild or severe COVID-19 during the follow-up (Figure 4G).